Celiac Disease
Celiac disease is a long-term autoimmune disorder characterized by extreme sensitivity to gluten, a protein found in wheat, rye, and barley, causing gastrointestinal issues such as diarrhea and abdominal pain, and damaging the small intestine, which leads to nutrient malabsorption and various other symptoms throughout the body. The only effective treatment is a strict gluten-free diet.
Health Outcomes
- Absence of Adverse Physiological Effects
- Accelerated Immune Response Maturation
- Accelerated Oral Tolerance Development
- Acceptability of Cheese Products
- Activated Immune Response
- Activated Intestinal Immune Response
- Activated Systemic Immunoreactivity in Peyer's Patches
- Adjusted Height-for-Age Z Score
- Adjusted Immune Function
- Adjusted Intestinal Microbiota Abundance
- Alleviated Intestinal Damage
- Alleviated Intestinal Disease
- Alleviated Intestinal Metabolic Disorders
- Altered Bifidobacterial Population
- Altered Colonic Microbial Communities
- Altered Cytokine Levels in Jejunal Mucosa
- Altered Dominant Intestinal Bacterial Composition
- Altered Dominant Microbial Community
- Altered Expression of Immune Products
- Altered Expression of Immune-Related Genes
- Altered Faecal Microbiota Profile
- Altered Fecal Butyrate Levels
- Altered Fecal Metabolite Levels
- Altered Gastrointestinal Microbial Communities
- Altered Gastrointestinal Microbiome Composition
- Altered Gut Metabolome
- Altered Gut Microbial Community
- Altered Gut Microbial Transcriptomic Response
- Altered IgA Concentration in Ileal Flushes
- Altered Intestinal Mucosa Morphology
- Altered Microbial Composition
- Altered Microbial Phyla Abundance
- Altered Relative Abundance of Specific Bacteria
- Altered Serum Immune Protein Levels
- Altered Short-Chain Fatty Acid Production
- Altered Short-Chain Fatty Acid Production by Gut Microbiota
- Altered Stool Microbiota Profile
- Altered T Cell Subsets
- Attenuated Enterocyte Injury
- Balanced Gut Microbiome
- Balanced Gut Microbiota
- Baseline Intestinal Permeability
- Binding to Goblet Cell Mucus
- Change in Immunoglobulin G Tissue Transglutaminase Levels
- Changed Magnesium Level
- Changed Phosphate Level
- Changed Stool Consistency
- Chronic Immune Activation
- Corrected Gut Microbiota Disorders
- Counterbalanced Gut Dysbiosis
- Decreased Digestive Enzyme Activities in Ileum
- Decreased Hafnia-Obesumbacterium Genus
- Decreased Naïve CD45RA+ T Helper Cells
- Decreased Total IgA Levels
- Degraded Non-Digestible Carbohydrates
- Delayed Onset of Colitis
- Delayed Onset of Type 1 Diabetes
- Delayed Onset of Type 1 Diabetes Mellitus
- Developed Anemia
- Disrupted Gut Microbiota Distribution
- Disrupted Mucosal Barrier
- Diversified B-Cell Populations in the Colon
- Diversified B-cell Populations in the Lamina Propria
- Elevated Fecal Acidic Steroid Levels
- Elevated Fecal IgA Levels
- Elevated Fecal Lactate Levels
- Elevated IgA Levels in Milk
- Elevated IgG-tTG Levels
- Elevated IgG1 Levels
- Elevated Serum Immunoglobulin Levels
- Elevated Serum Total Ig Levels
- Enhanced Adherence to Intestinal Epithelial Cells
- Enhanced Adhesion to Enterocyte-like Cells
- Enhanced Adjuvanticity
- Enhanced Antigen Uptake
- Enhanced Barrier Integrity
- Enhanced Beneficial Microbial Populations
- Enhanced Dendritic Cell Recruitment in Intestinal Villi
- Enhanced Differentiation of Intestinal Stem Cells into Goblet Cells
- Enhanced Digestive Process Survival
- Enhanced Diversity of Protective Bifidobacterial Populations
- Enhanced Food Safety
- Enhanced Functional Gene Presence in Small Intestine
- Enhanced GLP-2 Secretion
- Enhanced Gas Passing
- Enhanced Goblet Cell Regeneration
- Enhanced Growth and Development
- Enhanced Gut Flora Composition
- Enhanced Gut Health
- Enhanced Gut Microbiome Health
- Enhanced Gut Microbiota
- Enhanced Gut Microbiota Diversity
- Enhanced Gut Probiotic Levels
- Enhanced Host-Microbe Balance
- Enhanced Immune Function Post-Cessation
- Enhanced Immune Regulation
- Enhanced Immune Response
- Enhanced Immune Response Regulation
- Enhanced Immune Signaling Molecule Production
- Enhanced Immunogenicity
- Enhanced Immunomodulatory Function
- Enhanced Inflammatory Response
- Enhanced Innate Immune Response
- Enhanced Intestinal Barrier Function
- Enhanced Intestinal Cell Adhesion
- Enhanced Intestinal Defense Maturation
- Enhanced Intestinal Development
- Enhanced Intestinal Epithelial Cell Adhesion
- Enhanced Intestinal Epithelial Maturation
- Enhanced Intestinal Immunity
- Enhanced Intestinal Innate Mucosal Immunity
- Enhanced Intestinal Integrity
- Enhanced Intestinal Microbiota Maturation
- Enhanced Intestinal Morphometry
- Enhanced Intestinal Mucin Production
- Enhanced Intestinal Mucosal Cell Protection
- Enhanced Intestinal Repair Processes
- Enhanced Jejunal Immune Response
- Enhanced Lymphocyte Proliferation
- Enhanced Membrane Barrier Integrity
- Enhanced Metabolism in Small Intestine Microbiota
- Enhanced Mucosal Immune Response
- Enhanced Nutrient Bioavailability
- Enhanced Regulatory Immune System Development
- Enhanced SCFA Production
- Enhanced Small Intestine Metabolic Function
- Enhanced Specific IgG Response
- Enhanced T Cell Activation
- Enhanced Tight Junction Integrity
- Enhanced Type 1 Immune Response
- Ensured Safety for Human Consumption
- Equivalence in Growth Parameters
- Exercise-Induced Gastrointestinal Symptoms
- Gastrointestinal Tract Persistence
- Germination of Probiotics in Small Intestine
- Healthy Age-Appropriate Growth
- Healthy Gut Microbiome
- Impaired Intestinal Barrier Function
- Improved Abdominal Pain
- Improved Absorption of Essential Trace Elements
- Improved Abundance of Beneficial Bacteria
- Improved Adherence to Enterocytes
- Improved Age-Standardized Height
- Improved Alpha Diversity of Intestinal Microbiota
- Improved Amino Acid Absorption
- Improved Antigen-Specific IgA Secretion
- Improved Apparent Digestibility of Crude Protein
- Improved Beneficial Intestinal Microbiota
- Improved Bifidobacteria Levels
- Improved Bifidobacterium-Dominated Microbiota
- Improved Bioavailability
- Improved Bloating
- Improved Bloating Symptoms
- Improved Bone Health
- Improved Bowel Function
- Improved Bowel Habit Satisfaction
- Improved Bowel Habits
- Improved CD4- CD8+ low T Cell Percentage in Ileum
- Improved Calcium Absorption
- Improved Calcium Retention
- Improved Cell Adhesion
- Improved Coeliac Disease Symptoms
- Improved Colon Pain
- Improved Colonic Histology
- Improved Colonic Immune Response
- Improved Colonic Microbial Diversity
- Improved Colonic Mucosal Integrity
- Improved Community Diversity of Intestinal Microbiota
- Improved Constipation Symptoms
- Improved Consumer Acceptance
- Improved Crohn's Disease Symptoms
- Improved Crypt Hyperplasia
- Improved Cytokine Levels
- Improved Degradability of Acid Detergent Fiber
- Improved Dietary Component Retention
- Improved Digestibility
- Improved Digestibility of Amino Acids
- Improved Digestibility of Neutral Detergent Fiber
- Improved Digestive Efficiency
- Improved Digestive Enzyme Activity
- Improved Digestive Function
- Improved Digestive Health
- Improved Digestive Performance
- Improved Digestive Symptoms
- Improved Digestive Viability
- Improved Diversity of Gut Microbiota
- Improved Enteral Nutrition
- Improved Enteral Nutrition Tolerance
- Improved Enteral Nutrition Uptake
- Improved Epithelial Barrier Function
- Improved Epithelial Barrier Integrity
- Improved Epithelial Permeability
- Improved Faecal Dry Matter
- Improved Fecal Microbiota
- Improved Fecal Short-Chain Fatty Acid Levels
- Improved Feed Utilization
- Improved Flatus
- Improved Food Safety
- Improved Formula Tolerance
- Improved Functional Genes in Intestinal Microbiota
- Improved Gastrointestinal Resilience
- Improved Gastrointestinal Resistance
- Improved Gastrointestinal Score
- Improved Gastrointestinal Symptom Management
- Improved Gastrointestinal Symptom Rating Scale Score
- Improved Gastrointestinal Symptom Relief
- Improved Gastrointestinal Symptom Score
- Improved Gastrointestinal Symptoms
- Improved Gastrointestinal Tolerance
- Improved Gastrointestinal Transit Survival
- Improved Gastrointestinal Well-Being
- Improved General GI Health Status
- Improved General Tolerance
- Improved Gross Morphology of Intestinal Tissue
- Improved Growth
- Improved Growth Metrics
- Improved Growth Rate
- Improved Growth and Economic Traits
- Improved Growth in Children
- Improved Gut Adhesion
- Improved Gut Bacterial Diversity
- Improved Gut Barrier Function
- Improved Gut Barrier Morphology
- Improved Gut Flora Diversity
- Improved Gut Health
- Improved Gut Homeostasis
- Improved Gut Immunity
- Improved Gut Integrity
- Improved Gut Microbial Alpha Diversity
- Improved Gut Microbial Dysbiosis
- Improved Gut Microbial Persistence
- Improved Gut Microbial Population
- Improved Gut Microbial Richness
- Improved Gut Microbiome
- Improved Gut Microbiome Composition
- Improved Gut Microbiome Diversity
- Improved Gut Microbiome Function
- Improved Gut Microbiome Health
- Improved Gut Microbiome Recovery
- Improved Gut Microbiota Balance
- Improved Gut Microbiota Composition
- Improved Gut Microbiota Composition in Small Intestine
- Improved Gut Microbiota Distribution
- Improved Gut Microbiota Diversity
- Improved Gut Microbiota Fermentation
- Improved Gut Microbiota Homeostasis
- Improved Gut Microbiota Richness
- Improved Gut Microbiota Structure
- Improved Gut Microbiota-Related Pathways
- Improved Gut Microflora
- Improved Gut Morphology
- Improved Gut Mucosa Health
- Improved Gut Mucosal Histology
- Improved Gut Permeability
- Improved Gut Repair
- Improved Gut Tolerance
- Improved Height Percentile
- Improved Histopathological Protection
- Improved Humoral Immunity
- Improved IgA Production
- Improved IgG Response to Vaccination
- Improved Ileal Histomorphometry
- Improved Immune Parameters
- Improved Immune Regulation
- Improved Immune System Maturation
- Improved Immunity Status
- Improved Immunoglobulin Levels
- Improved Immunologic Barrier Function
- Improved Immunological Status of Mucosa
- Improved Immunomodulation
- Improved Inflammation Levels
- Improved Inflammatory Response
- Improved Intestinal Alkaline Phosphatase Activity
- Improved Intestinal Barrier
- Improved Intestinal Barrier Function
- Improved Intestinal Barrier Integrity
- Improved Intestinal Cell Adhesion
- Improved Intestinal Cell Integrity
- Improved Intestinal Cell Proliferation
- Improved Intestinal Cell Viability
- Improved Intestinal Crypt Survival
- Improved Intestinal Defense
- Improved Intestinal Defense Mechanism
- Improved Intestinal Development
- Improved Intestinal Digestive Enzyme Activity
- Improved Intestinal Environment
- Improved Intestinal Epithelial Barrier
- Improved Intestinal Epithelial Barrier Function
- Improved Intestinal Epithelial Cell Function
- Improved Intestinal Epithelial Intercellular Integrity
- Improved Intestinal Epithelial Permeability
- Improved Intestinal Epithelium Recovery
- Improved Intestinal Function
- Improved Intestinal Health
- Improved Intestinal Health from Zinc Deficiency Prevention
- Improved Intestinal Histology
- Improved Intestinal Histomorphology
- Improved Intestinal Histopathology
- Improved Intestinal Immune Barrier
- Improved Intestinal Immune Response
- Improved Intestinal Immune Responsiveness
- Improved Intestinal Immunity
- Improved Intestinal Immunomodulatory Function
- Improved Intestinal Innate Immunity
- Improved Intestinal Integrity
- Improved Intestinal Metabolism
- Improved Intestinal Microbial Composition
- Improved Intestinal Microbiota
- Improved Intestinal Microbiota Balance
- Improved Intestinal Microbiota Health
- Improved Intestinal Microenvironment
- Improved Intestinal Morphology
- Improved Intestinal Morphometry
- Improved Intestinal Mucosa Architecture
- Improved Intestinal Mucosal Health
- Improved Intestinal Mucosal Histology
- Improved Intestinal Mucosal Immunity
- Improved Intestinal Mucosal Repair
- Improved Intestinal Structure
- Improved Intestinal Villi Epithelium Integrity
- Improved Intestinal Villus Height
- Improved Intestinal Villus Morphology
- Improved Iron Absorption
- Improved Iron Deficiency Anemia Treatment Efficacy
- Improved Iron Levels
- Improved Iron Status
- Improved Irritable Bowel Syndrome Symptoms
- Improved Jejunal Health
- Improved Jejunal Morphology
- Improved Jejunal Permeability
- Improved Jejunal T-Cell Count
- Improved Lumbar Bone Mineral Density
- Improved Magnesium Bioaccessibility
- Improved Malnutrition Status
- Improved Microbial Community Composition
- Improved Microbial Diversity
- Improved Microbial Metabolism Regulation
- Improved Microbiota Activity
- Improved Microbiota Diversity
- Improved Microflora Composition
- Improved Micronutrient Availability
- Improved Micronutrient Status
- Improved Mineral Absorption
- Improved Mucosal Barrier Function
- Improved Nutrient Absorption
- Improved Nutrient Absorption and Metabolism
- Improved Nutrient Digestibility
- Improved Nutrient Levels
- Improved Nutrient Retention
- Improved Nutritional Content
- Improved Nutritional Status
- Improved Nutritional Value
- Improved Oral Tolerance
- Improved Overall Gastric Symptoms
- Improved Overall Gastrointestinal Symptoms
- Improved Overall IBS Symptoms
- Improved Palatability and Textural Quality
- Improved Probiotic Product Stability
- Improved Protein Absorption
- Improved Protein Digestion
- Improved Recovery of Intestinal Flora
- Improved Safety and Tolerability of Probiotic Consumption
- Improved Serum Albumin Levels
- Improved Short-Chain Fatty Acid Production
- Improved Specific Growth Rate
- Improved Spontaneous Bowel Movements
- Improved Stability of Gut Microbiota
- Improved Starch Digestibility
- Improved Stool Characteristics
- Improved Stool Formation
- Improved Stool Frequency
- Improved Stool Symptoms
- Improved Supplement Tolerance
- Improved Systemic Immune Response
- Improved Tight Junction Protein Localization
- Improved Tolerance to Intestinal Conditions
- Improved Tolerance to Saccharomyces cerevisiae
- Improved Total Volumetric Bone Mineral Density
- Improved Villus Height
- Improved Villus Height in Duodenum
- Improved Villus:Crypt Ratio
- Improved Vitamin A Content
- Improved Water Absorption
- Improved Zinc Absorption
- Increase in Beneficial Bifidobacterial Species
- Increased Abundance of Beneficial Microbes
- Increased Abundance of Beneficial SCFAs-Producing Bacteria
- Increased Abundance of Bifidobacterium
- Increased Acetic Acid in Stool
- Increased Adhesion to Enterocytes
- Increased Alpha Diversity of Jejunal Mucosa-Associated Microbiota
- Increased Anti-Inflammatory Cytokines in the Small Intestine
- Increased Antibody Production
- Increased Antigen-Specific IgG1 Levels
- Increased Apoptosis of OVA-specific TCR Tg T Cells
- Increased B Cell Populations
- Increased Bacteroides Levels in the Intestine
- Increased Beneficial Bacterial Species
- Increased Beneficial Gut Lactic Acid Bacteria
- Increased Beneficial Gut Microbiota
- Increased Beneficial Intestinal Metabolites
- Increased Beneficial Intestinal Microorganisms
- Increased Bifidobacteria Count
- Increased Bifidobacteriaceae Abundance
- Increased Bifidobacterial Counts
- Increased Bifidobacterial Population
- Increased Bifidobacterium Levels in Feces
- Increased Bifidobacterium lactis Proliferation in the Intestine
- Increased Bifidobacterium-Dominated Gut Microbiota
- Increased Bloating
- Increased Bowel Movement Frequency
- Increased Bowel Movements
- Increased Bowel Mucosal Mass
- Increased Butyrate Concentration
- Increased CD3d Expression in Colon During Weaning
- Increased CD4-Positive T-Lymphocytes in Ileal Epithelium
- Increased CD8 Percentage
- Increased Colon Barrier Biomarkers
- Increased Colonic Transepithelial Resistance
- Increased Colonization of S. thermophilus
- Increased Defecation Frequency
- Increased Diamine Oxidase Secretion
- Increased Diarrhea Incidence
- Increased Digestive Problem
- Increased Duodenal B-Lymphocyte Counts
- Increased Duodenal Inflammation
- Increased Duodenal Villus Height
- Increased Epithelial Proliferation in the Small Intestine
- Increased Excretion of Acidic Steroids in Feces
- Increased Faecal Carboxylic Acid Concentration
- Increased Fecal Acetate Levels
- Increased Fecal Bifidobacteria Numbers
- Increased Fecal Bifidobacterium Count
- Increased Fecal Calprotectin Levels
- Increased Fecal Concentration of Propionic Acid
- Increased Fecal Excretion
- Increased Fecal IgA Concentration
- Increased Fecal Immunoglobulin A Concentrations
- Increased Fecal Immunoglobulin A Levels
- Increased Fecal Immunological Biomarkers
- Increased Fecal Lactate Levels
- Increased Fecal Moisture
- Increased Fecal Moisture Content
- Increased Fecal Water Content
- Increased Fiber Carbohydrate Degradation Rate
- Increased Frequency of Complete Spontaneous Bowel Movements
- Increased Frequency of Loose or Watery Stools
- Increased Functional Gene Abundance in Small Intestine
- Increased GLP-2 Release
- Increased Gastrointestinal Discomfort
- Increased Gastrointestinal Symptoms
- Increased Generation of T Regulatory Cells
- Increased Gut Beneficial Microbes
- Increased Gut Microbial Growth
- Increased Helper T Cell Activation
- Increased IL-10/TNF-α Ratio in Intestinal Fluids
- Increased IgA Production
- Increased IgA Production by PPs
- Increased IgA-Inducing Activity
- Increased IgA-Secreting Lymphocytes in the Mucosa
- Increased Ileal Goblet Cell Count
- Increased Immune Marker Activation
- Increased Immune Marker Levels
- Increased Immunoglobulin A (IgA) Production
- Increased Immunoglobulin A (IgA)-Positive Cells
- Increased Immunoglobulin A Levels
- Increased Immunoglobulin A Levels in Breast Milk
- Increased Immunoglobulin A+ Cells in Small Intestine
- Increased Immunoglobulin G Levels
- Increased Immunoglobulin Levels
- Increased Incidence of Abdominal Symptoms
- Increased Indigenous Bifidobacterium Levels
- Increased Inflammatory Response
- Increased Interest in Nutritional Potential
- Increased Interleukin 12 Secretion from Dendritic Cells
- Increased Interleukin-8 Expression in the Ileum
- Increased Intestinal Bifidobacteria Levels
- Increased Intestinal Bifidobacteria Population
- Increased Intestinal Bifidobacterium Levels
- Increased Intestinal Cell Adhesion
- Increased Intestinal Epithelial Cell Adhesion
- Increased Intestinal IgA Levels
- Increased Intestinal IgA Secretion
- Increased Intestinal Immunoglobulin A Levels
- Increased Intestinal Inflammatory Response
- Increased Intestinal Lactobacillus sakei Levels
- Increased Intestinal Mucosal Immune Response
- Increased Intestinal Neutrophil Levels
- Increased Intestinal Permeability Under Exercise-induced Stress
- Increased Intestinal T-Cell Count
- Increased Intestinal Transit Rate
- Increased Intraepithelial Leukocyte Levels
- Increased Jejunal Permeability
- Increased Lacticaseibacillus Abundance
- Increased Lactobacilli Colonization in the Gut
- Increased Lymphocyte Proliferation
- Increased Lymphoid Cell Proliferation in Germ-Free Animals
- Increased Magnesium Absorption
- Increased Mast Cells in Mucosal Tissues
- Increased Mucosal Anti-Inflammatory Mediator MIF Production
- Increased Natural Killer Cell Frequency
- Increased Paneth Cell Number in Intestinal Crypts
- Increased Persistence of Beneficial Bacterial Species
- Increased Plasma Immunoglobulin Levels
- Increased Preference for SCFP-Containing Diet
- Increased Proportion of Bifidobacteria in Gut Microbiota
- Increased Proportion of Intestinal Goblet Cells
- Increased Protective Fecal Bifidobacteria
- Increased Protein Digestibility
- Increased Regulatory T Cell Count
- Increased Regulatory T Cell Populations
- Increased Regulatory T Cells in Intestinal Mucosa
- Increased Relative Abundance of Beneficial Bacteria
- Increased Resistance to Simulated Gastrointestinal Conditions
- Increased Rikenellaceae Abundance
- Increased SCFA Production
- Increased SCFA-Producing Bacteria
- Increased Sarcina Levels
- Increased Secretory Immunoglobulin A
- Increased Serum IgA Levels
- Increased Serum IgG2 Levels
- Increased Serum Immunoglobulin A (IgA) Levels
- Increased Serum Immunoglobulin Levels
- Increased Serum Immunoglobulins
- Increased Short-Chain Fatty Acid-Producing Bacteria
- Increased Specific Antibody Production
- Increased Specific IgG Levels
- Increased Stool Consistency
- Increased Stool Frequency
- Increased Stool IgA Levels
- Increased Stool Immunoglobulin A (IgA)
- Increased Stool Looseness
- Increased Stool Moisture Content
- Increased Stool Volume
- Increased Susceptibility to Salmonella Infection
- Increased Systemic Antibody Production
- Increased Tight Junction Proteins (Claudin-1)
- Increased Tolerance to Gastrointestinal Conditions
- Increased Tolerance to Inflammatory Stimuli
- Increased Tolerogenic Dendritic Cells in the Intestine
- Increased Total Fecal Carboxylic Acids
- Increased Total Immunoglobulin A (IgA) Levels
- Increased Treg Cell Fraction
- Increased Treg Population in the Small Intestine
- Increased Urinary Abundance of Nutrient-Related Metabolites
- Increased Valeric Acid Levels
- Increased Villus Height to Crypt Depth Ratio
- Increased ZO-1 Production in Ileal Tissues
- Induced Immunomodulatory Effects
- Induction of Th1 Immune Response
- Inflammatory Disease Protection
- Influence on Metabolic Pathways
- Influenced Systemic Immune Response
- Inhibited Changes in Short-Chain Fatty Acids
- Inhibited Digestive Enzyme Activity
- Inhibited α-Amylase Activity
- Lack of Long-Term Colonization of Bifidobacteria Strains
- Lack of Protection of Intestinal Morphology Against DON
- Lack of Sustainable Colonization
- Maintained Crypt Length
- Maintained Digestive Function
- Maintained Fecal Short Chain Fatty Acid Levels
- Maintained Gastrointestinal Health
- Maintained Gastrointestinal Microbiome Stability
- Maintained Growth Curve
- Maintained Growth Performance
- Maintained Gut Health
- Maintained Gut Homeostasis
- Maintained Gut Microbiome Composition
- Maintained Gut Microbiome Homeostasis
- Maintained Gut Microbiota Diversity
- Maintained Gut Microbiota Stability
- Maintained Gut Permeability
- Maintained Healthy Gut Environment
- Maintained Intestinal Barrier Function
- Maintained Intestinal Barrier Integrity
- Maintained Intestinal Epithelial Homeostasis
- Maintained Intestinal Immune Tolerance
- Maintained Intestinal Microbial Abundance
- Maintained Intestinal Microbiota Balance
- Maintained Intestinal Microbiota Stability
- Maintained Intestinal Villi Integrity
- Maintained Microbiota Equilibrium
- Maintained Mucosa-Associated Immunity
- Maintained Mucosal Barrier Integrity
- Maintained Mucus Barrier Integrity
- Maintained Normal Mucosal Barrier Function
- Maintained Nutritional Quality
- Maintained Small Intestinal Permeability
- Maintained Total Protein Levels
- Maintenance of Normal Intestinal Function
- Maintenance of Stable Gut Microbiota Profile
- Managed Gut Microbiota Disturbance
- Mature Gut Microbiota
- Microbial Group Modulation with Bifidobacterial Reduction
- Moderate Changes in Gastrointestinal Bacterial Groups
- Modification of Gastrointestinal Microbiome
- Modified Dominant Intestinal Bacterial Taxa
- Modified Fecal Microbiota
- Modulated Colonic Microbiota
- Modulated Gastrointestinal Hormone Levels
- Modulated Gut Microbial Diversity
- Modulated Gut Microbiome Composition
- Modulated Immune Function in Offspring
- Modulated Immune Markers
- Modulated Immune Response
- Modulated Immunologic Response
- Modulated Immunological Profile
- Modulated Inflammatory Cytokine Levels
- Modulated Inflammatory Response
- Modulated Intestinal Metabolite Profile
- Modulated Intestinal Microbial Community
- Modulated Intestinal Microbial Taxa
- Modulated Intestinal Microflora Composition
- Modulated Peripheral Immune Response
- Modulated Systemic Immune Response
- Modulated T Cell Response
- No Adverse Effects on Body Weight or Food Intake
- No Adverse Food Reactions
- No Change in Gastrointestinal Survival
- No Change in IgG-tTG Levels
- No Change in Inflammation Markers
- No Change in Intestinal Mucosa Morphology
- No Change in Newborn Growth
- No Improvement in Gastrointestinal Permeability
- No Improvement in Growth Performance
- No Significant Acute Effect on Calcium Metabolism
- No Significant Change in Duration of Gastrointestinal Symptoms
- No Significant Change in Gastrointestinal Symptoms
- No Significant Change in Gastrointestinal Tolerance
- No Significant Change in Growth Performance
- No Significant Change in Inflammatory Responses
- Normalized Gut Metabolites
- Normalized Gut Microbiota
- Normalized Serum IgA Levels
- Partial Restoration of Intestinal Cell Proliferation
- Presence of Enterocyte Vacuoles
- Presence of Lactobacillus rhamnosus in Feces
- Preserved Endogenous Bifidobacteria Composition
- Preserved Gastrointestinal Histological Structure
- Preserved Gut Microbiota Diversity
- Preserved Small Intestinal Villus Integrity
- Prevention of Aberrant Inflammatory Response
- Prevention of Intestinal Barrier Damage
- Promotion of Healthy Gut Microbial Colonization
- Protected Enterocyte Structure
- Protected Intestinal Health
- Protected Small Intestinal Integrity
- Protection Against Brush Border Damage Induced by Bacteria
- Protection Against Gut Tissue Damage
- Protection Against Intestinal Epithelial Injury
- Reduced Abdominal Cramping
- Reduced Abdominal Discomfort
- Reduced Abdominal Distension
- Reduced Abdominal Dysfunction
- Reduced Abdominal Pain
- Reduced Abdominal Pain Frequency
- Reduced Abdominal Pain Intensity
- Reduced Abdominal Pain Severity
- Reduced Abdominal Symptoms
- Reduced Abundance of Enterobacteriaceae Species
- Reduced Abundance of Pathobionts
- Reduced Abundance of Proteobacteria
- Reduced Abundance of Streptococcus Bacteroides Enterococcus Veillonella
- Reduced Acetate Production
- Reduced Adherence of Campylobacter jejuni to Intestinal Cells
- Reduced Aggravation of Chronic Inflammation
- Reduced Alkaline Phosphatase Level
- Reduced Anti-Enterococcus faecalis IgG Levels
- Reduced Antinutrient Levels
- Reduced Apolipoprotein B Level
- Reduced Apoptosis of Jejunal Mucosal Cells
- Reduced B Cell Count in Draining Lymph Nodes
- Reduced Bacteroides Abundance
- Reduced Bifidobacterium Counts
- Reduced Bifidobacterium longum
- Reduced Bloating
- Reduced Bloating Severity
- Reduced Blood Serum IgA Levels
- Reduced Body Mass
- Reduced Bowel Discomfort Symptoms
- Reduced Bowel Dysfunction
- Reduced Bowel Movements
- Reduced Butyrate Production
- Reduced Campylobacter jejuni Inhibition
- Reduced Clostridia Cluster XIV
- Reduced Clostridia Counts
- Reduced Clostridium Cluster IV Content
- Reduced Clostridium Species Numbers
- Reduced Coliform Levels in the Jejunum
- Reduced Colonic Atrophy
- Reduced Colonic Enterobacteriaceae Species
- Reduced Colonic Microscopic Damage
- Reduced Colonic Permeability
- Reduced Constipation
- Reduced Constipation Incidence
- Reduced Constipation Prevalence
- Reduced Constipation Symptoms
- Reduced Copper Level
- Reduced Crypt Cell Proliferation
- Reduced Crypt Depth
- Reduced Cytotoxic T Cells in Peyer's Patches
- Reduced Deferribacteres in Gut Microbiota
- Reduced Diarrhea Frequency
- Reduced Diarrhea Severity
- Reduced Digestive Symptoms
- Reduced Duration of Gastrointestinal Symptoms
- Reduced Dysbiosis
- Reduced Dysbiosis-Associated Bacteria Growth
- Reduced Dyspepsia Symptoms
- Reduced Enamel Hypomineralization
- Reduced Enamel Issue
- Reduced Enteritis
- Reduced Enteritis Index
- Reduced Enterobacteria Levels
- Reduced Enterocyte Damage
- Reduced Enteropathy
- Reduced Epithelial Barrier Disruption
- Reduced Epithelial Permeability
- Reduced FITC-Dextran Flux Upregulation
- Reduced Faecal Levels of Total Lactobacillus Species
- Reduced Faecal pH
- Reduced Fecal Acetate
- Reduced Fecal Bacterial Enzyme Activity
- Reduced Fecal Bacterial Nitroreductase Activity
- Reduced Fecal Bile Acid Levels
- Reduced Fecal Calprotectin Immunoglobulin A
- Reduced Fecal Calprotectin Levels
- Reduced Fecal Clostridium Levels
- Reduced Fecal Enterobacilli
- Reduced Fecal Excretion of Bacteroides Fragilis
- Reduced Fecal Loading
- Reduced Fecal Metabolite Levels
- Reduced Fecal Microbiota Diversity
- Reduced Fecal Score
- Reduced Fecal Staphylococcus aureus Populations
- Reduced Fermentation Time
- Reduced Ferritin Level
- Reduced Flatulence
- Reduced Flatulence Incidence
- Reduced Folate Deficiency
- Reduced Frequency of Defecation
- Reduced Fungal Enteric Colonization
- Reduced Gastric Acid Secretion
- Reduced Gastrointestinal Discomfort Symptoms
- Reduced Gastrointestinal Disease Incidence in Children
- Reduced Gastrointestinal Disease Symptoms
- Reduced Gastrointestinal Disorder Symptoms
- Reduced Gastrointestinal Disorders
- Reduced Gastrointestinal Inflammation
- Reduced Gastrointestinal Leakage
- Reduced Gastrointestinal Symptom Rating Scale Score
- Reduced Gastrointestinal Symptom Severity
- Reduced Gastrointestinal Symptoms Score
- Reduced Gastrointestinal Tract Histological Damage
- Reduced Gemmiger formicilis Abundance
- Reduced Genera Romboutsia
- Reduced Glucose Absorption
- Reduced Growth Performance
- Reduced Gut Barrier Defect
- Reduced Gut Damage
- Reduced Gut Disorders
- Reduced Gut Humoral Proinflammatory Response
- Reduced Gut Inflammation
- Reduced Gut Leakage
- Reduced Gut Membrane Barrier Damage
- Reduced Gut Permeability
- Reduced Gut Proteobacteria
- Reduced Hard Stool
- Reduced Harmful Gut Microbiota
- Reduced Harmful Intestinal Metabolites
- Reduced Humoral Immunity to Bacteroides thetaiotaomicron
- Reduced IL-10 Expression in Ileum
- Reduced IL-18 Expression in Ileum
- Reduced IL-1β Expression in Ileum
- Reduced IgA tTG Antibody Concentrations
- Reduced Ileum Mucosa Damage
- Reduced Immune-Mediated Pathologies
- Reduced Immunogenicity After Oral Vaccination
- Reduced Immunoinflammatory Markers
- Reduced Impact on Existing Indigenous Microbiota
- Reduced Incidence of Chronic Diarrhea
- Reduced Incidence of Diarrhoea in Children
- Reduced Incidence of Gastrointestinal Adverse Events
- Reduced Incidence of Watery Diarrhea
- Reduced Inflammation
- Reduced Inflammation Levels
- Reduced Inflammation in Intestinal Enterocytes
- Reduced Inflammation in Premature Intestinal Cells
- Reduced Inflammation via Gut Microbiota
- Reduced Inflammatory Diseases
- Reduced Inflammatory Effects
- Reduced Inflammatory Factor Production
- Reduced Inflammatory Parameters
- Reduced Inflammatory Pathway Activity
- Reduced Inflammatory Processes
- Reduced Inflammatory Response in Intestinal Cells
- Reduced Inflammatory Tone
- Reduced Interferon-Gamma Production
- Reduced Intestinal Aging
- Reduced Intestinal Cell Adhesion
- Reduced Intestinal Cell Death
- Reduced Intestinal Cholesterol Absorption
- Reduced Intestinal Damage
- Reduced Intestinal Epithelial Apoptosis
- Reduced Intestinal Histological Damage
- Reduced Intestinal Hyperpermeability
- Reduced Intestinal Immune Cell Count
- Reduced Intestinal Immunopathology
- Reduced Intestinal Inflammation
- Reduced Intestinal Inflammation Severity
- Reduced Intestinal Mucosal Immune Response
- Reduced Intestinal NE Lesion Score
- Reduced Intestinal Oxidative Damage
- Reduced Intestinal Pathology
- Reduced Intestinal Pathology Changes
- Reduced Intestinal Permeability
- Reduced Intestinal Permeability Defect
- Reduced Intestinal Proinflammatory Cytokine Levels
- Reduced Intestinal Salmonella Burden
- Reduced Intestinal Symptoms from Carbohydrate Sensitivity
- Reduced Intestinal Tissue Damage
- Reduced Intestinal Tissue Injury
- Reduced Intestinal Transit Time
- Reduced Irritable Bowel Syndrome Symptoms
- Reduced LPS Translocation
- Reduced Lactose Intolerance Symptoms
- Reduced Low-grade Intestinal Inflammation
- Reduced Lower Intestinal pH
- Reduced Macromolecule Permeability
- Reduced Median Levels of IgA-tTG
- Reduced Metabolic Functions of Intestinal Microbiota
- Reduced Methanobrevibacter Levels
- Reduced Microbial Richness
- Reduced Microbial Translocation
- Reduced Morphological Damage of the Jejunum
- Reduced Mucosal Cytokine Response
- Reduced Mucosal Damage
- Reduced Mucosal Inflammation
- Reduced Mucosal Permeability
- Reduced Mucosal Pro-Inflammatory Activity
- Reduced Mucosal Thickness
- Reduced Mycotoxin Bioavailability
- Reduced NDF Digestibility
- Reduced Neurally Evoked Ion Secretion in the Colon
- Reduced Neutrophil Recruitment
- Reduced Nutrient Content
- Reduced Nutritional Status
- Reduced Occurrence of Soft Stools
- Reduced Oral Aphthae Symptoms
- Reduced Oral Aphthosis Frequency
- Reduced Oxalate Nephropathy
- Reduced Oxidative Stress in Ileum Mucosa
- Reduced Oxidative Stress in Intestinal Epithelial Cells
- Reduced P1NP Level
- Reduced Pathogen Association
- Reduced Pathogen Translocation to Visceral Tissues
- Reduced Pathological Characteristics of the Intestinal Tract
- Reduced Pathological Symptoms
- Reduced Phosphorus Level
- Reduced Plasma IgG Production
- Reduced Plasma Vitamin K Levels
- Reduced Precursor Amino Acid Availability
- Reduced Prevalence of Gastric Symptoms
- Reduced Prevalence of Iron Deficiency
- Reduced Prevalence of Proteobacteria
- Reduced Pro-Inflammatory Bacteria Levels
- Reduced Pro-Inflammatory Cytokine Interleukin-15 Levels
- Reduced Pro-Inflammatory Fatty Acids
- Reduced Pro-inflammatory Cytokine Expression in Ileum
- Reduced Pro-inflammatory Effect
- Reduced Pro-inflammatory Immune Responses
- Reduced Proliferation of CD4(+) T Cells
- Reduced Prolonged Diarrhea
- Reduced Proportion of Patients with Loose Stools
- Reduced Proportion of Proteobacteria
- Reduced Red Blood Cell Folate Concentration
- Reduced Relative Abundance of Bacteroidales
- Reduced Relative Abundance of Escherichia-Shigella
- Reduced Relative Abundance of Sutterella
- Reduced Richness Indicators in Ileum
- Reduced Risk of Colorectal Cancer
- Reduced Risk of Infection
- Reduced Risk of Low Bone Mineral Density
- Reduced Risk of Obesity
- Reduced Ruminococcus Abundance
- Reduced S. Enteritidis Invasion
- Reduced Secretory IgA Content in Faeces
- Reduced Secretory Immunoglobulin A in Stools
- Reduced Serum Diamine Oxidase Activity
- Reduced Serum Ferritin Levels
- Reduced Serum Somatostatin Levels
- Reduced Severe Necrotizing Enterocolitis (NEC)
- Reduced Severity of Gastrointestinal Disorders
- Reduced Short-Chain Fatty Acid Levels in the Colon
- Reduced Short-Chain Fatty Acids (SCFA)
- Reduced Sitosterol Absorption
- Reduced Small Intestinal Transit Time
- Reduced Small-Intestinal Damage
- Reduced Small-Intestinal Enteropathy
- Reduced Small-intestinal Ulcers
- Reduced Stool Consistency
- Reduced Stool pH
- Reduced Stress-Induced Intestinal Hyperpermeability
- Reduced Susceptibility to Enteric Infection
- Reduced Symptoms of Oral Aphthous Ulcers
- Reduced Threonine
- Reduced Time to Maximum Amino Acid Concentration
- Reduced Transepithelial Resistance
- Reduced Turicibacter Abundance
- Reduced Urease Activity
- Reduced Urgency of Bowel Movements
- Reduced Urinary Calcium Level
- Reduced Urinary MMA Levels
- Reduced Valeric Acid Levels
- Reduced Villus Atrophy
- Reduced Villus Height
- Reduced Vitamin B12 Level
- Reduced Vitamin E Level
- Reduced Weight Gain and Fat Mass
- Reduced Weight Loss
- Reduced Whole Gut Transit Time
- Reduced Zinc Level
- Reduced Zonulin Level
- Regression of Gastrointestinal Disorders
- Regulated Gut Microbiota
- Regulated Gut Microbiota Metabolic Function
- Regulated Host Epithelial Cells
- Regulated Immune Cell Proliferation
- Regulated Immune Response
- Regulated Inflammatory Responses
- Regulated Intestinal Barrier Function
- Regulated Intestinal Microbiota
- Regulated Intestinal Microorganisms
- Regulated Microbial Metabolism
- Regulated Microbiota Function
- Relieved Abdominal Dysfunction
- Relieved Gastrointestinal Symptoms
- Relieved Intestinal Impairments
- Remodeled Intestinal Microbiota
- Requirement for Sustained Dosage in Gastrointestinal Tract
- Resolved Keratomalacia
- Restored Barrier Function
- Restored Digestive Enzyme Activity
- Restored Goblet Cell Count
- Restored Gut Microbiome Balance
- Restored Gut Microbiota Diversity
- Restored Gut Microbiota Homeostasis
- Restored Gut Microbiota Structure
- Restored Healthy Gut Microbial Balance
- Restored Immune Organ Structure
- Restored Intestinal Barrier Function
- Restored Intestinal Structure
- Restored Microbial Balance
- Restored Microbiome Composition
- Restored Mucus Layer Integrity
- Restored Protective Effect in Colitis
- Safe Drug Administration
- Safe for Consumption with No Adverse Immune Effects
- Stabilized Gut Microbiota
- Stabilized Intestinal Microbiota
- Stable Bowel Function
- Stable Fecal pH
- Stable Immune System Responses
- Stimulation of Immune Cells
- Suppressed Enterobacteriaceae Levels
- Survival Through Human Intestine
- Sustained Bifidobacteria Populations
- Sustained Immune Activity
- Unchanged Duration of Diarrhoea in Outpatient Children
- Unchanged Gastrointestinal Resistance
- Unchanged Gastrointestinal Symptoms
- Unchanged Intestinal Bacterial Concentrations
- Unchanged Stool Consistency or Bowel Frequency
- Unchanged Stool Frequency
- Worsened Fecal Scores
- Worsened IBS Symptoms